Inhibition of BMI-1 Induces Apoptosis through Downregulation of DUB3-Mediated Mcl-1 Stabilization

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• BMI-1 is a polycomb oncogene overexpressed in cancers, regulating proliferation, invasion, and apoptosis.
• BMI-1 functions as a cancer stemness marker, crucial for maintaining stem cell self-renewal.
• Understanding BMI-1's regulatory mechanisms is key to developing novel cancer therapies.

Purpose of the Study:

• To investigate the effects of BMI-1 inhibition on cancer stem-like cells and cancer cell death.
• To elucidate the molecular mechanisms underlying BMI-1's role in cancer progression.
• To identify potential therapeutic targets for BMI-1-driven cancers.

Main Methods:

• Pharmacological inhibition of BMI-1 using PTC596.
• Knockdown of BMI-1 using small interfering RNA (siRNA).
• Analysis of Mcl-1 and DUB3 protein and mRNA levels.
• Investigation of the proteasome-ubiquitin system and apoptosis pathways.

Main Results:

• Inhibition or knockdown of BMI-1 reduced cancer stem-like cells and increased cancer cell death.
• BMI-1 inhibition led to post-translational downregulation of Mcl-1 protein via the proteasome-ubiquitin system.
• PTC596 and BMI-1 siRNA decreased DUB3 deubiquitinase levels, correlating with Mcl-1 destabilization.
• Overexpression of Mcl-1 or DUB3 counteracted the apoptotic effects induced by PTC596.

Conclusions:

• BMI-1 inhibition destabilizes Mcl-1 protein by downregulating DUB3, leading to cancer cell death.
• The BMI-1/DUB3/Mcl-1 axis represents a critical pathway in cancer stemness and survival.
• Targeting BMI-1 offers a promising therapeutic strategy for cancers characterized by high BMI-1 expression.